Comment on ‘Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures’

समान संसाधन

• Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures
  द्वारा: Nathell, Lennart, और अन्य
  प्रकाशित: (2019)
• Comment on ‘Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron(III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ Between 2014 and 2017’
  द्वारा: Schaffalitzky de Muckadell, Philip, और अन्य
  प्रकाशित: (2019)
• Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management
  द्वारा: Rampton, David, और अन्य
  प्रकाशित: (2014)
• Severe hypophosphataemia after intravenous iron administration
  द्वारा: Anand, Gurpreet, और अन्य
  प्रकाशित: (2017)
• Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide
  द्वारा: Siderov, J, और अन्य
  प्रकाशित: (2002)